logo
South Korea Lab Makes Bird Flu 100% Lethal In Mammals

South Korea Lab Makes Bird Flu 100% Lethal In Mammals

Gulf Insider13-06-2025
South Korean scientists have conducted a lab experiment that made a purported wild avian influenza 'bird flu' virus 100% lethal in mammals, achieving total death in infected mice by enabling the virus to adapt inside their bodies and spread to others.
The dangerous move comes as the U.S. develops a 'next-generation' universal vaccine platform called 'Generation Gold Standard' that will focus on avian influenza jab creation, signaling a coordinated international push to engineer and preemptively vaccinate against lab-enhanced bird flu strains with pandemic potential—despite worldwide fallout from similar COVID-era strategies.Published June 2025 in Virology Journal , the study describes how researchers at Konkuk University infected mice with a highly pathogenic H5N1 avian influenza strain—one that already contained a small percentage (4%) of a mammalian-adaptive mutation known as PB2-E627K.
That tiny minority of mutant virus was enough to take over and kill every infected host.
'All challenged mice died by 8 dpc. Transmission through direct-contact occurred in 100% of cases, and all contact mice died within 12 days.'
This was not an accidental discovery.
Researchers intentionally infected mammals with a virus they knew contained a mutation that helps bird flu spread and replicate more effectively in mammals, including humans.
Once inside the mice, the mutation exploded to near-total dominance—not just in the lungs, but in the brain, where it caused seizures, ataxia, and fatal neurological damage.
'The PB2-E627K variant, initially present at 4% in the virus stock, was selected and reached near-fixation (~ 100%) in the lungs and brains by 6 days post-challenge and was subsequently transmitted.'
'In dead direct-contact mice, the E627K mutation in PB2 was found at a proportion of 99.8–100% in both the lungs and brains.'
The virus became neurotropic—targeting the brain—and caused seizures and other neurological symptoms before death.
'Two out of three direct-contact mice displayed significant neurological symptoms, including seizure, ataxia, and bradykinesia.'
This is precisely the kind of gain-of-function-style research that Congressional hearings and federal reports have linked to the origins of the COVID-19 pandemic—a disaster that killed over a million Americans and possibly far more if COVID vaccine injury data is fully accounted for.
'Even a small proportion of mammalian-adaptive mutations can quickly become dominant as the virus serially transmits between mammals.'
The virus strain used in the study—isolated from a wild duck in Korea—was given to mice intranasally at high dose.
After just one round of infection, the mutation that enables efficient replication in mammals (PB2-E627K) went from 4% to nearly 100%, and was then passed to other mice who also died.
'In experiment 2, with a 1:1 challenge-to-contact ratio, all the challenged mice died. Transmission occurred in 50% of cases; three out of six contact mice died.'
This was not nature running its course—this was a deliberate laboratory setup that triggered a lethal evolutionary pathway, with full awareness of the risks.
No genetic engineering was needed—just the right environment and host to favor viral adaptation.
This is exactly the kind of procedure that reportedly allowed a bat coronavirus to become a pandemic-capable human pathogen in Wuhan.
'These findings highlight the need for continuous genomic monitoring to detect mammalian adaptation markers and assess interspecies transmission risks.'
Yet this isn't the only high-risk bird flu experiment South Korea is conducting.
Just a month earlier, South Korean scientists published another Virology Journal paper revealing that they had engineered a chimeric H5N1 virus using hallmark gain-of-function (GOF) techniques—combining gene segments from three different influenza viruses to increase the virus's heat resistance, alter host targeting, and enhance human cell entry.
'Recombinant viruses were generated using a pHW2000 plasmid-based reverse genetics system.'
'Combining the R90K and H110Y mutations (22W_KY) resulted in a synergistic increase in thermal stability and maintained HA activity without measurable reduction even after 4 h at 52 °C.'
'22 W HA and 22 W NA genes, along with six internal genomic segments (PB2, PB1, PA, NP, M, NS) from PR8 and a PB2 gene from 01310 containing the I66M, I109V, and I133V (MVV) mutations'
The study also confirmed enhanced antigen uptake and intracellular penetration in human cells:
'The highest level of intracellular entry was observed for BEI_22W_KY, confirming its superior effectiveness in penetrating cells.'
These GOF enhancements—increased thermostability, host retargeting, and replication modulation—were achieved without any mention of special oversight or biosecurity risk assessments, despite the White House having confirmed that the COVID-19 pandemic was caused by a virus engineered using similar techniques.
The timing raises concern, especially as the U.S. Department of Health and Human Services recently launched a $500 million 'next-generation' bird flu vaccine initiative, drawing direct parallels between vaccine development programs and risky virological engineering.
If any of these engineered viruses escape containment—accidentally or intentionally—they could ignite a global pandemic, ironically the very scenario these experiments claim to prevent.
This particular mouse-killing study was performed in Biosafety Level 3 facilities at Konkuk University, sanctioned by the university's Institutional Biosafety and Animal Care Committees:
'All experiments involving viable HPAI H5N1 viruses were conducted at a Biosafety Level (BSL)-3 facilities (Konkuk University) in accordance with procedures approved by the Konkuk University Institutional Biosafety Committee (approval no. KUIBC-2024-06).'
'Animal infection studies were reviewed, approved, and supervised by the Institutional Animal Care and Use Committee of Konkuk University (approval no. KU24080).'
The COVID pandemic taught the world what happens when supposed mammal-adaptive viruses leak from research settings.
Yet instead of a global moratorium on these reckless experiments, labs are still running trials that kill every mammal they infect—and worse, documenting how to do it again.
Also read: Saudi Arabia Edge South Korea On Penalties To Reach AFC U-17 Asian Cup Final
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

COVID-19 Pandemic Accelerated Brain Aging Even In People Who Didn't Get Virus: Study
COVID-19 Pandemic Accelerated Brain Aging Even In People Who Didn't Get Virus: Study

Gulf Insider

time3 days ago

  • Gulf Insider

COVID-19 Pandemic Accelerated Brain Aging Even In People Who Didn't Get Virus: Study

Brain aging appears to have accelerated by several months during the COVID-19 pandemic, even in people who did not get sick from the virus, according to a new study. The study, published in the journal Nature Communications on July 22, found that in 2021 and 2022, brain scans from a large UK database showed signs of aging, including brain shrinkage, even in individuals who were never infected. Although people who had a COVID-19 infection showed some declines in overall cognitive performance, the authors said that structural brain changes were seen across a larger population. They highlighted pandemic-related stressors, such as anxiety, social isolation, and economic and health insecurity, as possible reasons for the increase in brain aging. The research suggested that the pandemic may have also prematurely aged some individuals' brains by an average of 5.5 months, even among those who never contracted the virus. The impacts of the pandemic on the brain were most pronounced in men and people from 'deprived socio-demographic backgrounds,' the study said. The team analyzed brain scans collected from 15,334 healthy adults, with an average age of 63, in the UK Biobank—a long-term monitoring program—and then used machine-learning models to examine 'hundreds of structural features of the participants' brains, which taught the model how the brain looks at various ages,' the study's lead author, Ali-Reza Mohammadi-Nejad, a researcher at the University of Nottingham, stated in a paper released alongside the study. After that, they applied the model to a group of 996 healthy UK Biobank participants who had two brain scans at least 'a couple of years apart,' he added. Some participants had one scan done before the pandemic and another following the onset of the pandemic, in early 2020, the study stated. 'What surprised me most was that even people who hadn't had Covid showed significant increases in brain ageing rates,' Mohammadi-Nejad said in a statement. 'It really shows how much the experience of the pandemic itself, everything from isolation to uncertainty, may have affected our brain health.' The long-term impacts of the brain changes aren't clear, the team of researchers said, but they concluded that there is a need to 'address health and socio-economic inequalities in addition to lifestyle factors to mitigate accelerated brain ageing.' More research is also crucial to 'improve brain health outcomes in future public health crises,' they added. The U.S. Centers for Disease Control and Prevention said in an update several days ago that COVID-19 cases are rising in some parts of the United States, although the overall levels for the virus remain low. COVID-19 activity, the CDC said on July 18, is now increasing in some Southeast, Southern, and West Coast states. Citing wastewater data for COVID-19, the agency said that positive tests are increasing around the United States, while emergency department visits appear to be increasing among children aged 0 to 4. Wastewater detections for COVID-19 updated by the CDC suggest that high levels of the virus are being reported in California, Florida, Hawaii, Louisiana, Nevada, South Carolina, and Texas. No states were experiencing very high levels, according to a map from the agency.

Vaccination Rates Are Stagnating
Vaccination Rates Are Stagnating

Gulf Insider

time7 days ago

  • Gulf Insider

Vaccination Rates Are Stagnating

Data published last week by the World Health Organization (WHO) and UNICEF confirm that global vaccination coverage has stagnated in recent years. In 2024, 14.3 million children worldwide were classified as 'zero-dose', meaning they had not received a single vaccine. This number has barely changed over the past two years (14.5 million in 2022) and remains higher than the 12.8 million recorded in 2019, before the Covid-19 pandemic disrupted health services. More than half of these unvaccinated children live across around 30 countries currently affected by fragility, conflict or other vulnerabilities. As Statista's Anna Fleck shows in the following chart, the percentage of children who received three doses of the DTP vaccine (which protects against diphtheria, tetanus, and pertussis) stood at 85 percent in 2024. This is slightly below from the 86 percent reached between 2016 and 2019. You will find more infographics at Statista Vaccination rates for other diseases have also stagnated: polio coverage remained at 84 percent in 2024 (down from 86 percent between 2017 and 2019), and tuberculosis vaccination held steady at 88 percent (compared to a peak of 90 percent in 2017 and 2018). As for measles, global coverage improved significantly between 2004 and 2016 but has since slowed. In 2024, the global measles vaccination rate reached 76 percent, up from 71 percent in 2019, yet still well below the 95 percent threshold needed to effectively prevent outbreaks. According to the WHO, 60 countries experienced 'major or disruptive' measles outbreaks in 2024 – nearly double the number recorded in 2022. The primary reason for low vaccination coverage remains limited access to vaccines in certain regions. However, the WHO also highlights the growing threat posed by misinformation about science and vaccines. Also read: US Government Drops Charges Against Doctor Who Issued Fake COVID Vaccination Cards

CDC: COVID-19 Infections Rise In Some Parts Of US
CDC: COVID-19 Infections Rise In Some Parts Of US

Gulf Insider

time22-07-2025

  • Gulf Insider

CDC: COVID-19 Infections Rise In Some Parts Of US

While activity for COVID-19 remains low in the United States, recent statistics released by the Centers for Disease Control and Prevention (CDC) show that infections are rising in parts of the country. The CDC said in a July 18 update that 'COVID-19 activity is increasing in many Southeast, Southern, and West Coast states. COVID-19 levels are ranked as 'low,' the second-lowest level on the CDC's scale, according to the update. Citing wastewater data for COVID-19, the agency said that positive tests are increasing around the United States, while emergency department visits appear to be increasing among children ages 0 to 4. Wastewater detections for COVID-19 updated by the CDC suggest that high levels of the virus are being reported in California, Florida, Hawaii, Louisiana, Nevada, South Carolina, and Texas. No states were experiencing very high levels, according to a map from the agency. Seasonal influenza activity is considered by the CDC to be low, and RSV activity is considered very low, the CDC said. Overall, U.S. respiratory illness activity, which refers to 'how frequently a wide variety of respiratory symptoms and conditions are diagnosed by emergency department doctors,' remains very low. Other illnesses that are covered in the update include Mycoplasma pneumoniae, sometimes called 'walking pneumonia,' which the CDC said has become elevated in some parts of the United States over the past several weeks. Mycoplasma pneumoniae, a type of bacteria, can cause upper respiratory tract infections but sometimes causes pneumonia, researchers say. Meanwhile, cases of whooping cough, or pertussis, 'are lower than their peak in November 2024, although they remain elevated in 2025 compared with immediately before the COVID-19 pandemic.' Whooping cough has the highest risk of causing severe disease and complications in children ages 1 and younger, according to the Mayo Clinic. Symptoms of the bacterial infection include a bout of coughing fits that can last weeks, vomiting while coughing, as well as a characteristic 'whooping' sound that occurs during inhalation after the coughing fits. The CDC has not updated its COVID-19 variant estimates since mid-June. In the last update, it noted that there were growing proportions of variants such as NB.1.8.1 and XFG, which were both declared 'variants under monitoring' by the World Health Organization (WHO) in May and June, respectively. 'The available evidence on NB.1.8.1 does not suggest additional public health risks relative to the other currently circulating Omicron descendent lineages,' the WHO said about the NB.1.8.1 strain. The U.N. health body issued a similar statement about the XFG variant in June. The NB.1.8.1 appears to have been driving a rise in cases across mainland China since earlier this year. Because of the Chinese Communist Party's history of blocking access to information and publishing inaccurate data, including underreporting COVID-19 infections and related deaths since 2020, information provided by local doctors and health workers is more valuable for understanding the situation on the ground there. The recent CDC update comes after agency researchers said that COVID-19 appears to follow a twice-per-year pattern. Cases usually peak in the summer, or July through September, before peaking again in the winter, or December through February. 'Our analysis revealed biannual COVID-19 peaks in late summer and winter, a pattern that is expected to persist as long as the rapid evolution of SARS-CoV-2 and cyclical S1 diversity continues,' CDC researchers wrote in a report released earlier this month.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store